Texas Oncology - Sherman
Sherman, Texas, United States
Cancer treatment center in Sherman, Texas
2800 N Hwy 75, Sherman, TX 75090
About Texas Oncology - Sherman
"Texas Oncology is an independent private practice with more than 500 physicians and 210 locations across the state. Meeting the oncology needs of Texans for more than 35 years, the practice includes Texas Center for Proton Therapy, Texas Breast Specialists, Texas Oncology Surgical Specialists, and Texas Center for Interventional Surgery. As a lead participant in US Oncology Research, Texas Oncology played a role in the development of more than 100 FDA-approved therapies."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Radiation Therapy Oncology Group
11
Eli Lilly and Company
6
Gilead Sciences
3
National Cancer Institute (NCI)
3
Calithera Biosciences, Inc
2
Mirati Therapeutics Inc.
2
Alliance for Clinical Trials in Oncology
1
Bayer
1
Biotheranostics, Inc.
1
Eisai Inc.
1
GRAIL, LLC
1
Clinical Trials at Texas Oncology - Sherman
During the past decade, Texas Oncology - Sherman conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 21 clinical trials were completed, i.e. on
average, 105% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 10 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
2005-03-01
2018-08-01
Completed
4,216
Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer
2005-12-01
2022-05-20
Completed
612
Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
2006-01-01
2016-12-01
Completed
1,173
Radiation Therapy in Treating Patients With Stage II Prostate Cancer
2006-04-01
2022-12-22
Completed
1,116
Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer
2006-12-01
2016-12-01
Completed
63
High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
2007-11-01
2022-05-20
Completed
544
Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors
2008-03-01
2016-12-01
Completed
554
Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer
2008-02-01
Active, not recruiting
1,792
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Texas Oncology - Sherman" #1 sponsor was "Radiation Therapy Oncology Group" with 11 trials, followed by "Eli Lilly and Company" with 6 trials
sponsored, "Gilead Sciences" with 3 trials sponsored, "National Cancer Institute (NCI)" with 3 trials sponsored and "Calithera Biosciences, Inc"
with 3 trials sponsored. Other sponsors include 14 different institutions and
companies that sponsored additional 23 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Texas Oncology - Sherman"
#1 collaborator was "NRG Oncology" with 14 trials as a collaborator, "National Cancer Institute (NCI)" with 14 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator and "Radiation Therapy Oncology Group" with 2 trials as a collaborator. Other collaborators include 6 different institutions and companies that were
collaborators in the rest 16 trials.
Clinical Trials Conditions at Texas Oncology - Sherman
According to Clinical.Site data, the most researched conditions in "Texas Oncology - Sherman" are
"Breast Cancer" (5 trials), "Prostate Cancer" (4 trials), "Metastatic Breast Cancer" (3 trials), "Non-Small Cell Lung Cancer" (3 trials) and "Breast Neoplasms" (2 trials). Many other conditions were trialed in "Texas Oncology - Sherman" in a lesser frequency.
Clinical Trials Intervention Types at Texas Oncology - Sherman
Most popular intervention types in "Texas Oncology - Sherman" are "Drug" (31 trials), "Radiation" (17 trials), "Biological" (9 trials), "Other" (6 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.
The name of intervention was led by "Abemaciclib" (4 trials), "Carboplatin" (4 trials), "Docetaxel" (4 trials), "Paclitaxel" (4 trials) and "Laboratory Biomarker Analysis" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Texas Oncology - Sherman
The vast majority of trials in "Texas Oncology - Sherman" are
32 trials for "All" genders, 8 trials for "Female" genders and 4 trials for "Male" genders.
Clinical Trials Status at Texas Oncology - Sherman
Currently, there are NaN active trials in "Texas Oncology - Sherman".
undefined are not yet recruiting,
7 are recruiting,
12 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 18 completed trials in Texas Oncology - Sherman,
undefined suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Texas Oncology - Sherman, 0 "Phase 1"
clinical trials were conducted, 12 "Phase 2" clinical
trials and 26 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".